drugset / Trial / NCT00319865
PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Prospective multicenter phase 2 study using PAD and Thal/Dex combination sequentially.
Timeline
- Start
- 2005-11
- Primary completion
- —
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | — | — |
| Subject | Dexamethasone | Small molecule | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Thalidomide | Other / unclassified | — | — |